The US and the EU have agreed to work on disease surveillance and vaccine research

The US and the EU have agreed to work on disease surveillance and vaccine research

President Joe Biden and European Commission Chief Ursula von der Leyen announced on Thursday that the US and EU have agreed to collaborate on disease monitoring and vaccine research. On the occasion of the second Global COVID-19 Summit, the two leaders released a joint statement. “The EU and the US will collaborate to improve pathogen monitoring and threat assessment, leveraging existing and novel approaches, providing integrated surveillance, real-time monitoring, early warning systems, forecasting and analytics, intelligence exchange, supporting rapid response networks, and a ‘always-ready’ health emergency workforce to prevent or mitigate cross-border outbreaks,” according to the statement. They also pledged to boost cooperation in research and development for new vaccines, therapeutics and diagnostics.

The COVID-19 summit, hosted by the governments of the United States, Belize, Germany, Indonesia, and Senegal, convened heads of state, health professionals and experts from all over the world in order to work out joint strategies in fighting the virus. During the summit, the US also reaffirmed its pledge to expand investments in bilateral global health security programs. The county committed an extra $200 million to the World Bank’s fund to prevent pandemics. The European Union promised to provide $450 million for the pandemic preparedness and global health security financial intermediary fund at the World Bank. In addition, European countries made their individual pledges.

“Acknowledging the importance of swiftly reacting to pandemics, the US and EU support science to shorten the cycle for the development of safe and effective vaccines, therapeutics and diagnostics from 300 to 100 days following the identification of such threats and work to make them widely available. In the near term, the EU and the US. committed to deepening cooperation to identify and evaluate variant adapted, more broadly protective, and next generation vaccines, therapeutics and diagnostics, while ensuring their safety and efficacy,” the statement said.

Check the latest news about World news section for best information.

The best source of news -
Compare items
  • Total (0)